IP Library Granted Patent US 11,073,470
Granted Patent B2
US 11,073,470 · App. 15/113,128 · Granted Jul 27, 2021

Attenuated total reflectance-based biosensor for conformation and secondary structure analysis

Inventors: Klaus Gerwert (Münster, DE); Jens Wiltfang (Essen, DE); Julian Ollesch (Witten, DE); Andreas Nabers (Markt Schwaben, DE); Jonas Schartner (Helmstedt, DE); Carsten Kötting (Bochum, DE)
Assignee: Betasense GMBH
G01N21/3577G01N21/552G01N21/6428G01N21/6458G01N33/6896G01N21/05G01N2021/6421G01N2800/2821G01N2800/2835
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,073,470
App. No.
15/113,128
Granted
Jul 27, 2021
Kind
B2
Abstract

Provided herein is a biosensor for conformation and secondary structure analysis, notably for the direct non-invasive qualitative secondary structure analysis of a single selected protein within a complex mixture, as e.g. a body fluid, by vibrational spectroscopic methods. For the analysis it is not required that the selected substance be isolated, concentrated, or pretreated by a special preparative procedure.

Claims (48)

1. An infrared sensor element adapted for detection of different conformations of a secondary structure of a biomarker protein that undergoes conformational transitions associated with disease progression, wherein the infrared sensor element comprises:

a germanium internal reflection element of a trapezoid or parallelogram shape, which internal reflection element is transparent in an infrared spectrum,

comprises a functionalized surface, and

is configured to provide for at least five internal reflections at the functionalized surface,

and

an antibody directly grafted to the functionalized surface, wherein the antibody specifically binds

(i) amino acid residues 13-28 of amyloid-beta, or

(ii) amino acid residues 103-108 of alpha-synuclein,

which antibody binds (i) or (ii) independent of the conformation of the secondary structure of amyloid-beta or of alpha-synuclein,

and

wherein the infrared sensor element is configured to detect different conformations of the secondary structure of the amyloid-beta or of alpha-synuclein in a body fluid from a patient,

wherein the functionalized surface is produced by a method comprising

directly grafting the antibody to at least one surface of said germanium internal reflection element by silanization with short silane linkers or by thiolation with short thiol linkers, wherein the short silane linkers and short thiol linkers have a chain length of not more than 20 atoms,

reacting freely accessible amine groups of said antibody with amine-reactive groups on the short silane linkers or the short thiol linkers, and

blocking remaining amine-reactive groups on the short silane linkers or the short thiol linkers with a blocking substance that is not cross-reactive with the biomarker protein.

2. The infrared sensor element of claim 1 , wherein the germanium internal reflection element

is a germanium monocrystal.

3. The infrared sensor element of claim 1 , wherein the short silane linkers and short thiol linkers include homogenous silane and thiol linkers, mixtures of silane linkers and mixtures of thiol linkers, wherein

the silane linkers have one of the following formulas:

X 3 Si—(CH 2 ) n —Y—(CH 2 ) n′ —Z,

X 2 R 1 Si—(CH 2 ) n —Y—(CH 2 ) n′ —Z or

X(R 1 ) 2 Si—(CH 2 ) n —Y—(CH 2 ) n′ —Z,

and the thiol linkers have the following formula:

HS—(CH 2 ) n —Y—(CH 2 ) n′ —Z,

wherein X at each occurrence is independently selected from halogen and C 1-6 alkoxy, n is an integer of 1 to 10, n is an integer of 1 to 5; R 1 at each occurrence is independently selected from C 1-6 alkyl, Y is selected from a chemical bond, O—, —CO—, —SO 2 —, —NR 2 —, —S—, —SS—, —NR 2 CO—, —CONR 2 —, —NR 2 SO 2 — and —SO 2 NR 2 —, wherein R 2 is H or C 1-6 alkyl, and Z is an amine-reactive group.

4. The infrared sensor element of claim 3 , wherein the germanium internal reflection element comprises

(i) silane linkers and in the linkers X is independently selected from C 1-6 alkoxy-groups, Y is —NHCO—, Z is —CO 2 H or an ester derivative thereof, and n is an integer of 1 to 5 and n′ is an integer of 1 to 3; or

(ii) thiol linkers and in the linkers Y is a chemical bond, Z is —CO 2 H or an ester derivative thereof, and n is an integer of 1 to 8 and n′ is an integer of 1 to 5.

5. The infrared sensor element of claim 1 , wherein the blocking substance is selected from casein, ethanolamine, L-lysine, polyethylene glycols and derivatives thereof.

6. The infrared sensor element of claim 1 , wherein the blocking substance is detergent-free and comprises a globular protein that is not cross-reactive with the biomarker protein.

7. The infrared sensor element of claim 1 , wherein the blocking substance is casein.

8. The infrared sensor element of claim 1 , wherein the antibody directly grafted to the functionalized surface specifically binds amino acid residues 13-28 of amyloid-beta.

9. An infrared sensor element comprising:

a germanium internal reflection element of a trapezoid or parallelogram shape, which internal reflection element

is transparent in the infrared spectrum,

comprises a functionalized surface, and

is configured to provide for at least five internal reflections at the functionalized surface,

and

an antibody directly grafted to the functionalized surface, wherein the antibody specifically binds

(i) amino acid residues 13-28 of amyloid-beta, or

(ii) amino acid residues 103-108 of alpha-synuclein,

which antibody binds (i) or (ii) independent of the conformation of the secondary structure of amyloid-beta or of alpha-synuclein, and

wherein the infrared sensor element is configured to detect different conformations a secondary structure of the amyloid-beta or of alpha-synuclein in a body fluid from a patient.

10. The sensor of claim 9 , wherein the body fluid is cerebrospinal fluid, blood, serum, or plasma.

11. The infrared sensor element of claim 9 , wherein the germanium internal reflection element is a germanium monocrystal.

12. The infrared sensor element of claim 9 , wherein the antibody directly grafted to the functionalized surface specifically binds amino acid residues 13-28 of amyloid-beta.

13. The infrared sensor element of claim 12 , wherein the body fluid is cerebrospinal fluid, blood, serum, or plasma.

14. The infrared sensor element of claim 1 , wherein the antibody directly grafted to the functionalized surface specifically binds amino acid residues 13-28 of amyloid-beta.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2021
From: RUHR-UNIVERSITÄT BOCHUM
To: IR-DIAGNOSTICS IP HOLDING UG
Reel/Frame 056148/0265 →
CHANGE OF NAME Recorded May 5, 2021
From: IR-DIAGNOSTICS IP HOLDING UG
To: BETASENSE GMBH
Reel/Frame 056151/0765 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2021
From: UNIVERSITÄT DUISBURG-ESSEN
To: RUHR-UNIVERSITÄT BOCHUM
Reel/Frame 056092/0611 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2021
From: UNIVERSITÄT DUISBURG-ESSEN
To: RUHR-UNIVERSITAT BOCHUM
Reel/Frame 055150/0481 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2016
From: GERWERT, KLAUS; WILTFANG, JENS; OLLESCH, JULIAN; NABERS, ANDREAS; SCHARTNER, JONAS; KÖTTING, CARSTEN
To: RUHR-UNIVERSITÄT BOCHUM; UNIVERSITÄT DUISBURG-ESSEN
Reel/Frame 039209/0129 →
Priority Claims (1)
EP 14155138 · Feb 14, 2014 · regional
Continuity (1)
Related Publication 20170010212A1 · Jan 12, 2017